PUBLISHER: TechNavio | PRODUCT CODE: 1975634
PUBLISHER: TechNavio | PRODUCT CODE: 1975634
Global Acute Respiratory Distress Syndrome Treatment Market 2026-2030
The global acute respiratory distress syndrome treatment market is forecasted to grow by USD 1432.1 mn during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of predisposing conditions and growing global geriatric population, continuous technological advancements in respiratory care and life support systems, rising healthcare expenditure and infrastructure development in emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.7% |
| CAGR | 7.1% |
| Incremental Value | $1432.1 mn |
Technavio's global acute respiratory distress syndrome treatment market is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Oral
- Injection
- Inhalation
By Drug Class
- Corticosteroids and antibiotics
- Vasoconstrictors
- Bronchodilators
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the focus on personalized medicine and ards phenotyping as one of the prime reasons driving the global acute respiratory distress syndrome treatment market growth during the next few years. Also, growing emphasis on non-invasive and less invasive respiratory support and integration of artificial intelligence and digital health for predictive and optimized care will lead to sizable demand in the market.
The report on the global acute respiratory distress syndrome treatment market covers the following areas:
- Global acute respiratory distress syndrome treatment market sizing
- Global acute respiratory distress syndrome treatment market forecast
- Global acute respiratory distress syndrome treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global acute respiratory distress syndrome treatment market vendors that include Air Liquide SA, Dragerwerk AG and Co. KGaA, Fisher and Paykel Healthcare, Fresenius Medical Co. KGaA, GE HealthCare Technologies, Getinge AB, Hamilton Medical AG, ICU Medical Inc., Koninklijke Philips N.V., LivaNova PLC, Loewenstein Medical, Mallinckrodt Plc, Medtronic Plc, Nihon Kohden Corp., Shenzhen Mindray Co. Ltd., Terumo Corp., ZOLL Medical Corp.. Also, the global acute respiratory distress syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024 ($ million)
- 5.2 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.3 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- 5.4 Drug Class segment analysis 2020 - 2024
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 The impact of AI on global acute respiratory distress syndrome treatment market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Distribution Channel
- 8.1 Market segments
- 8.2 Comparison by Distribution Channel
- 8.3 Hospitals pharmacies - Market size and forecast 2025-2030
- 8.4 Retail pharmacies - Market size and forecast 2025-2030
- 8.5 Online pharmacies - Market size and forecast 2025-2030
- 8.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- 9.2 Comparison by Route of Administration
- 9.3 Oral - Market size and forecast 2025-2030
- 9.4 Injection - Market size and forecast 2025-2030
- 9.5 Inhalation - Market size and forecast 2025-2030
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Drug Class
- 10.1 Market segments
- 10.2 Comparison by Drug Class
- 10.3 Corticosteroids and antibiotics - Market size and forecast 2025-2030
- 10.4 Vasoconstrictors - Market size and forecast 2025-2030
- 10.5 Bronchodilators - Market size and forecast 2025-2030
- 10.6 Others - Market size and forecast 2025-2030
- 10.7 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Taiwan - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Israel - Market size and forecast 2025-2030
- 12.6.7 Turkey - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of predisposing conditions and growing global geriatric population
- Continuous technological advancements in respiratory care and life support systems
- Rising healthcare expenditure and infrastructure development in emerging economies
- 13.2 Market challenges
- Dual challenge of exorbitant treatment costs and absence of disease-modifying pharmacotherapies
- Clinical heterogeneity and diagnostic complexity of syndrome
- Intricate and high-risk clinical trial design and execution
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Focus on personalized medicine and ARDS phenotyping
- Growing emphasis on non-invasive and less invasive respiratory support
- Integration of artificial intelligence and digital health for predictive and optimized care
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Air Liquide SA
- Air Liquide SA - Overview
- Air Liquide SA - Business segments
- Air Liquide SA - Key news
- Air Liquide SA - Key offerings
- Air Liquide SA - Segment focus
- SWOT
- 15.5 Dragerwerk AG and Co. KGaA
- Dragerwerk AG and Co. KGaA - Overview
- Dragerwerk AG and Co. KGaA - Business segments
- Dragerwerk AG and Co. KGaA - Key offerings
- Dragerwerk AG and Co. KGaA - Segment focus
- SWOT
- 15.6 Fisher and Paykel Healthcare
- Fisher and Paykel Healthcare - Overview
- Fisher and Paykel Healthcare - Product / Service
- Fisher and Paykel Healthcare - Key news
- Fisher and Paykel Healthcare - Key offerings
- SWOT
- 15.7 Fresenius Medical Co. KGaA
- Fresenius Medical Co. KGaA - Overview
- Fresenius Medical Co. KGaA - Business segments
- Fresenius Medical Co. KGaA - Key news
- Fresenius Medical Co. KGaA - Key offerings
- Fresenius Medical Co. KGaA - Segment focus
- SWOT
- 15.8 GE HealthCare Technologies
- GE HealthCare Technologies - Overview
- GE HealthCare Technologies - Business segments
- GE HealthCare Technologies - Key news
- GE HealthCare Technologies - Key offerings
- GE HealthCare Technologies - Segment focus
- SWOT
- 15.9 Getinge AB
- Getinge AB - Overview
- Getinge AB - Business segments
- Getinge AB - Key news
- Getinge AB - Key offerings
- Getinge AB - Segment focus
- SWOT
- 15.10 Hamilton Medical AG
- Hamilton Medical AG - Overview
- Hamilton Medical AG - Product / Service
- Hamilton Medical AG - Key offerings
- SWOT
- 15.11 ICU Medical Inc.
- ICU Medical Inc. - Overview
- ICU Medical Inc. - Product / Service
- ICU Medical Inc. - Key offerings
- SWOT
- 15.12 Koninklijke Philips N.V.
- Koninklijke Philips N.V. - Overview
- Koninklijke Philips N.V. - Business segments
- Koninklijke Philips N.V. - Key news
- Koninklijke Philips N.V. - Key offerings
- Koninklijke Philips N.V. - Segment focus
- SWOT
- 15.13 Loewenstein Medical
- Loewenstein Medical - Overview
- Loewenstein Medical - Product / Service
- Loewenstein Medical - Key offerings
- SWOT
- 15.14 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- 15.15 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.16 Nihon Kohden Corp.
- Nihon Kohden Corp. - Overview
- Nihon Kohden Corp. - Business segments
- Nihon Kohden Corp. - Key offerings
- Nihon Kohden Corp. - Segment focus
- SWOT
- 15.17 Shenzhen Mindray Co. Ltd.
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
- 15.18 ZOLL Medical Corp.
- ZOLL Medical Corp. - Overview
- ZOLL Medical Corp. - Product / Service
- ZOLL Medical Corp. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
